Endothelial progenitor cells in angiogenesis

( views:79, downloads:0 )
Author:
Xu Qing-bo()
Journal Title:
ACTA PHYSIOLOGICA SINICA
Issue:
Volume 57, Issue 01, 2005
DOI:
Key Word:
EPC;bone marrow;stem cells;angiogenesis and atherosclerosis

Abstract´╝Ü Circulating blood contains a subtype of progenitor cells that have the capacity to differentiate into mature endothelial cells in vitro and in vivo. These cells have been termed endothelial progenitor cells (EPCs). The isolation of EPCs by adherence culture or magnetic microbeads has been described. EPCs are characterized by the expression of 3 markers, CD 133, CD34, and the vascular endothelial growth factor receptor-2. After differentiation, EPCs express CD31, vascular endothelial cadherin, and von Willebrand factor. Evidence is accumulating that EPCs can facilitate endothelial repair and angiogenesis in vivo. We observed that EPCs can regenerate damaged endothelial cells in vascular grafts in apoE-deficient mice, and that abundant vascular progenitor cells are present in the adventitia of the vessel wall. It is not clear yet, however, whether these EPCs are essential for these angiogenic and atherogenic processes. Moreover, there are still many uncertainties about how cardiovascular risk factors alter EPC function. Thus, further studies on the mechanisms of EPC homing, releasing and attaching will be of help to explore areas of potential basic research and clinical application of EPCs.

  • [1]Asahara T, Murohara T, Sullivan A, Silver M, van der Zee R, Li T, Witzenbichler B, Schatteman G, Isner JM. Isolation of putative progenitor endothelial cells for angiogenesis. Science 1997; 275:964-967.
  • [2]Kawamoto A, Gwon HC, Iwaguro H, Yamaguchi JI, Uchida S,Masuda H, Silver M, Ma H, Kearney M, Isner JM, Asahara T.Therapeutic potential of ex vivo expanded endothelial progenitor cells for myocardial ischemia. Circulation 2001; 103: 634-637.
  • [3]Lin Y, Weisdorf DJ, Solovey A, Hebbel RP. Origins of circulating endothelial cells and endothelial outgrowth from blood. J Clin Invest 2000; 105: 71-77.
  • [4]Asahara T, Masuda H, Takahashi T, Kalka C, Pastore C, Silver M, Kearne M, Magner M, Isner JM. Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization. Circ Res 1999; 85: 221-228.
  • [5]Crosby JR, Kaminski WE, Schatteman G, Martin PJ, Raines EW, Seifert RA, Bowen-Pope DF. Endothelial cells of hematopoietic origin make a significant contribution to adult blood vessel formation. Circ Res 2000; 87: 728-730.
  • [6]Hu Y, Zhang Z, Torsney E, Afzal AR, Davison F, Metzler B, Xu Q. Abundant progenitor cells in the adventitia contribute to atherosclerosis of vein grafts in ApoE-deficient mice. J Clin Invest 2004; 113: 1258-1265.
  • [7]Planat-Benard V, Silvestre JS, Cousin B, Andre M, Nibbelink M, Tamarat R, Clergue M, Manneville C, Saillan-Barreau C,Duriez M, Tedgui A, Levy B, Penicaud L, Casteilla L. Plasticity of human adipose lineage cells toward endothelial cells: physiological and therapeutic perspectives. Circulation 2004; 109: 656-663.
  • [8]Gepstein L. Derivation and potential applications of human embryonic stem cells. Circ Res 2002; 91: 866-876.
  • [9]Doetschman TC, Eistetter H, Katz M, Schmidt W, Kemler R.The in vitro development of blastocyst-derived embryonic stem cell lines: formation of visceral yolk sac, blood islands and myocardium. J Embryol Exp Morphol 1985; 87: 27-45.
  • [10]Hristov M, Erl W, Weber PC. Endothelial progenitor cells:mobilization, differentiation, and homing. Arterioscler Thromb Vasc Biol 2003; 23:1185-1189.
  • [11]Szmitko PE, Fedak PW, Weisel RD, Stewart DJ, Kutryk MJ,Verma S. Endothelial progenitor cells: new hope for a broken heart. Circulation 2003; 107: 3093-3100.
  • [12]Yeh ET, Zhang S, Wu HD, Korbling M, Willerson JT, Estrov Z.Transdifferentiation of human peripheral blood CD34+-enriched cell population into cardiomyocytes, endothelial cells, and smooth muscle cells in vivo. Circulation 2003; 108: 2070-2073.
  • [13]Badorff C, Brandes RP, Popp R, Rupp S, Urbich C, Aicher A,Fleming I, Busse R, Zeiher AM, Dimmeler S. Transdifferentiation of blood-derived human adult endothelial progenitor cells into functionally active cardiomyocytes. Circulation 2003; 107: 1024-1032.
  • [14]Balsam LB, Wagers AJ, Christensen JL, Kofidis T, Weissman IL, Robbins RC. Haematopoietic stem cells adopt mature haematopoietic fates in ischaemic myocardium. Nature 2004; 428:668-673.
  • [15]Murry CE, Soonpaa MH, Reinecke H, Nakajima H, Nakajima HO, Rubart M, Pasumarthi KB, Virag JI, Bartelmez SH, Poppa V, Bradford G, Dowell JD, Williams DA, Field LJ. Haematopoietic stem cells do not transdifferentiate into cardiac myocytes in myocardial infarcts. Nature 2004; 428: 664-668.
  • [16]Quaini F, Urbanek K, Beltrami AP, Finato N, Beltrami CA,Nadal-Ginard B, Kajstura J, Leri A, Anversa P. Chimerism of the transplanted heart. N Engl J Med 2002; 346: 5-15.
  • [17]Hur J, Yoon CH, Kim HS, Choi JH, Kang HJ, Hwang KK, Oh BH, Lee MM, Park YB. Characterization of two types of endothelial progenitor cells and their different contributions to neovasculogenesis. Arterioscler Thromb Vasc Biol2004; 24: 288-293.
  • [18]Kalka C, Masuda H, Takahashi T, Kalka-Moll WM, Silver M,Kearney M, Li T, Isner JM, Asahara T. Transplantation of ex vivo expanded endothelial progenitor cells for therapeutic neovascularization. Proc Natl Acad Sci USA 2000; 97: 3422-3427.
  • [19]Takahashi T, Kalka C, Masuda H, Chen D, Silver M, Keamey M, Magner M, Isner JM, Asahara T. Ischemia- and cytokineinduced mobilization of bone marrow-derived endothelial progenitor cells for neovascularization. Nat Med 1999; 5: 434-438.
  • [20]Stary HC. Evolution and progression of atherosclerotic lesions in coronary arteries of children and young adults. Arteriosclerosis 1989; 9: I19-I32.
  • [21]Hansson GK, Libby P, Schonbeck U, Yan ZQ. Innate and adaptive immunity in the pathogenesis of atherosclerosis. Circ Res 2002; 91: 281-291.
  • [22]Stary HC, Chandler AB, Glagov S, Guyton JR, Insull W Jr,Rosenfeld ME, Schaffer SA, Schwartz CJ, Wagner WD, Wissler RW. A definition of initial, fatty streak, and intermediate lesions of atherosclerosis. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association. Circulation 1994; 89: 2462-2478.
  • [23]Gerritsen ME. Functional heterogeneity of vascular endothelial cells. Biochem Pharmacol 1987; 36: 2701-2711.
  • [24]Schnittler HJ. Structural and functional aspects of intercellular junctions in vascular endothelium. Basic Res Cardiol 1998; 93 Suppl 3: 30-39.
  • [25]Schwartz SM, Benditt EP. Cell replication in the aortic endothelium: a new method for study of the problem. Lab Invest 1973; 28: 699-707.
  • [26]Schwartz SM, Benditt EP. Clustering of replicating cells in aortic endothelium. Proc Natl Acad Sci USA 1976;73:651-653.
  • [27]Caplan BA, Schwartz CJ. Increased endothelial cell turnover in areas of in vivo Evans Blue uptake in the pig aorta. Atherosclerosis 1973; 17: 401-417.
  • [28]Zou Y, Dietrich H, Hu Y, Metzler B, Wick G, Xu Q. Mouse model of venous bypass graft arteriosclerosis. Am J Pathol 1998;153: 1301-1310.
  • [29]Dietrich H, Hu Y, Zou Y, Huemer U, Metzler B, Li C, Mayr M,Xu Q. Rapid development of vein graft atheroma in ApoEdeficient mice. Am J Pathol 2000; 157: 659-669.
  • [30]Zhang SH, Reddick RL, Piedrahita JA, Maeda N. Spontaneous hypercholesterolemia and arterial lesions in mice lacking apolipoprotein E. Science 1992; 258:468-471.
  • [31]Zhang L, Freedman NJ, Brian L, Peppel K. Graft-extrinsic cells predominate in vein graft arterialization. Arterioscler Thromb Vasc Biol2004; 24: 470-476.
  • [32]Vasa M, Fichtlscherer S, Adler K, Aicher A, Martin H, Zeiher AM, Dimmeler S. Increase in circulating endothelial progenitor cells by statin therapy in patients with stable coronary artery disease. Circulation 2001; 103: 2885-2890.
  • [33]Walter DH, Rittig K, Bahlmann FH, Kirchmair R, Silver M,Murayama T, Nishimura H, Losordo DW, Asahara T, Isner JM.Statin therapy accelerates reendothelialization: a novel effect involving mobilization and incorporation of bone marrow-derived endothelial progenitor cells. Circulation 2002; 105: 3017-3024.
  • [34]Werner N, Junk S, Laufs U, Link A, Walenta K, Bohm M, Nickenig G. Intravenous transfusion of endothelial progenitor cells reduces neointima formation after vascular injury. Circ Res 2003;93: e17-e24.
  • [35]Werner N, Priller J, Laufs U, Endres M, Bohm M, Dirnagl U,Nickenig G. Bone marrow-derived progenitor cells modulate vascular reendothelialization and neointimal formation: effect of 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibition.Arterioscler Thromb Vasc Biol2002; 22: 1567-1572.
  • [36]Griese DP, Ehsan A, Melo LG, Kong D, Zhang L, Mann MJ,Pratt RE, Mulligan RC, Dzau VJ. Isolation and transplantation of autologous circulating endothelial cells into denuded vessels and prosthetic grafts: implications for cell-based vascular therapy.Circulation 2003; 108: 2710-2715.
  • [37]Simper D, Wang S, Deb A, Holmes D, McGregor C, Frantz R,Kushwaha SS, Caplice NM. Endothelial progenitor cells are decreased in blood of cardiac allograft patients with vasculopathy and endothelial cells of noncardiac origin are enriched in transplant atherosclerosis. Circulation 2003; 108: 143-149.
  • [38]Hoffmann J, Haendeler J, Aicher A, Rossig L, Vasa M, Zeiher AM, Dimmeler S. Aging enhances the sensitivity of endothelial cells toward apoptotic stimuli: important role of nitric oxide. Circ Res 2001; 89: 709-715.
  • [39]Goldschmidt-Clermont PJ. Loss of bone marrow-derived vascular progenitor cells leads to inflammation and atherosclerosis. Am Heart J 2003; 146: S5-S12.
  • [40]Rauscher FM, Goldschmidt-Clermont PJ, Davis BH, Wang T,Gregg D, Ramaswami P, Pippen AM, Annex BH, Dong C, Taylor DA. Aging, progenitor cell exhaustion, and atherosclerosis.Circulation 2003; 108: 457-463.
  • [41]Xu Q. Mouse models of arteriosclerosis: From arterial injuries to vascular grafts. Am J Pathol 2004; 165: 1-10.
WanfangData CO.,Ltd All Rights Reserved
About WanfangData | Contact US
Healthcare Department, Fuxing Road NO.15, Haidian District Beijing, 100038 P.R.China
Tel:+86-010-58882616 Fax:+86-010-58882615 Email:yiyao@wanfangdata.com.cn